aap Implantate Balance Sheet Health
Financial Health criteria checks 3/6
aap Implantate has a total shareholder equity of €14.2M and total debt of €1.2M, which brings its debt-to-equity ratio to 8.1%. Its total assets and total liabilities are €21.1M and €6.9M respectively.
Key information
8.1%
Debt to equity ratio
€1.16m
Debt
| Interest coverage ratio | n/a |
| Cash | €1.40m |
| Equity | €14.21m |
| Total liabilities | €6.92m |
| Total assets | €21.13m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AAQ1's short term assets (€12.6M) exceed its short term liabilities (€5.1M).
Long Term Liabilities: AAQ1's short term assets (€12.6M) exceed its long term liabilities (€1.8M).
Debt to Equity History and Analysis
Debt Level: AAQ1 has more cash than its total debt.
Reducing Debt: AAQ1's debt to equity ratio has increased from 0.4% to 8.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if AAQ1 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if AAQ1 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.